CELL VIABILITY: AN INDISPENSABLE INDICATOR OF DRUG SAFETY & TOXICITY
Cell viability and proliferation are critical pieces of information for assessing drug safety and toxicity. Depending on the disease of interest, drug-development campaigns may seek to enhance cell repopulation, as in degenerative diseases, or inhibit it, as in cancer.
Our Ready-2-Go assay service provides multi-parameter assessments that quantitatively measure cell proliferation, apoptosis, and viability in multiple cell types.
KEY FEATURES
Choose A549, U-2 OS, or Hep G2 cells
Multiplexed measurements of proliferation, apoptosis, and cell viability
Only 4-6 weeks from assay to report
Option to bundle R2G Services or transition to Custom Services
BUILD A GENERAL FRAMEWORK OF TOXICITY
Bundle this service with our Ready-2-Go Mitochondrial Health Assay Service to gain a better understanding of your therapeutics' impact on cell viability.
RELATED READY-2-GO SERVICES
Browse related Ready-2-Go assay offerings. For custom assays, check out our Custom Services.
R2G MITOCHONDRIAL HEALTH
Screen for changes in mitochondrial membrane potential.
Learn more
R2G LUNG FIBROSIS
Stress fibers are measured in NHLFs.
Learn more
R2G NEUROTOXICITY
Multiplexed readouts of viability and apoptosis.
Learn more